Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.53 |
| ▸ | ALPI | P09923 | 1/20 | 0.53 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.53 |
| ▸ | XIAP | P98170 | 1/20 | 0.53 |
| ▸ | SLC15A1 | P46059 | 2/20 | 0.46 |
| ▸ | LTA4H | P09960 | 1/20 | 0.44 |
| ▸ | CTSC | P53634 | 1/20 | 0.43 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.43 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.43 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.42 |
| ▸ | SRR | Q9GZT4 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14095437 | 0.94 | ALPI (0.59) | SLC7A5ALPIPKMPTGS1XIAP | |
| SCHEMBL17874602 | 0.94 | ALPI (0.59) | SLC7A5ALPIPKMPTGS1XIAP | |
| SCHEMBL12928633 | 0.94 | ALPI (0.59) | SLC7A5ALPIPKMPTGS1XIAP | |
| SCHEMBL1147651 | 0.91 | SLC7A5 (0.59) | SLC7A5ALPIPKMPTGS1XIAP | |
| SCHEMBL7019120 | 0.91 | SLC7A5 (0.59) | SLC7A5ALPIPKMPTGS1XIAP | |
| SCHEMBL26359430 | 0.89 | ALPI (0.66) | SLC7A5ALPIPKMPTGS1XIAP | |
| SCHEMBL15679078 | 0.89 | ALPI (0.66) | SLC7A5ALPIPKMPTGS1XIAP | |
| Phenylalanine SCHEMBL2929469 | 0.88 | SLC7A5 (0.71) | SLC7A5ALPIPKMPTGS1XIAP | |
| Tetraethylene Glycol SCHEMBL2929245 | 0.88 | SLC7A5 (0.71) | SLC7A5ALPIPKMPTGS1XIAP | |
| SCHEMBL2496771 | 0.87 | ALPI (0.51) | SLC7A5ALPIPKMPTGS1XIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023216533-A1 | INDOLE ALKALOID, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 南京中医药大学 | 2023-11-16 | — | — | WO | disclosed |
| US-10421843-B2 | Poly(ester amide) macromers and polymers thereof | CORNELL UNIVERSITY (US) | 2019-09-24 | — | — | US | disclosed |
| US-20130059998-A1 | Poly(Ester Amide) Macromers and Polymers Thereof | CORNELL UNIVERSITY | 2013-03-07 | — | — | US | disclosed |
| WO-2011112700-A2 | POLY(ESTER AMIDE) MACROMERS AND POLYMERS THEREOF | CORNELL UNIVERSITY (US) | 2011-09-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130059998-A1 | Poly(Ester Amide) Macromers and Polymers Thereof | PAM, PARG, MAX | SLC7A5 712/4885ALPI 4541/4885PKM 492/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.